Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Busy address KBO
20 other companies have their registered office at the same address; threshold 10.
Financials
Financial year 2025
The Oncidium Foundation from Oudergem, company number BE0838388420, closed financial year 2025 with a result of € 9.3 million after tax. For that financial year The Oncidium Foundation recorded a gross margin of € -1.3 million and equity of € 59.6 million. Compared with financial year 2024, the result moved from € 19.6 million to € 9.3 million. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 8, 2026.
€ 59.6 million
▲ 19% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 9.3 million
▼ 52% vs 2024
Profit after tax over the fiscal year.
€ 474,746
▼ 91% vs 2024
Cash and bank balances on the last day of the fiscal year.
People and assets in 2025
12.8
▲ 4.9 vs 2024
Average over the fiscal year, from the social balance sheet.
€ 1.2 million
▲ 38% vs 2024
€ 91,800 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
Debts at end 2025
€ 20,100
▼ 99% vs 2024
Loans from banks and other lenders, long and short.
€ 363,801
▲ € 304,017 vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 216,560
▲ 218% vs 2024
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|
| Gross margin | € -589,954 | € -1,299,780 | ▼ € 709,825 |
| Profit after taxes | € 19,612,674 | € 9,325,810 | ▼ 52% |
| Equity | € 50,290,324 | € 59,616,135 | ▲ 19% |
| Total debts | € 4,198,201 | € 844,386 | ▼ 80% |
| Cash | € 5,001,853 | € 474,746 | ▼ 91% |
| Retained profit | € 50,290,324 | € 59,616,135 | ▲ 19% |
| Bank debt | € 3,848,574 | € 20,100 | ▼ 99% |
| Balance sheet total | € 54,488,525 | € 60,460,521 | ▲ 11% |
| Employees (FTE) | 7.9 | 12.8 | ▲ 4.9 |
Key figures of The Oncidium Foundation, fiscal years 2024 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to The Oncidium Foundation?
What happened at The Oncidium Foundation in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 9.3 million (▼ 52% vs 2024). Source: NBB ↗
- Soumya Chandramouli became a director. NBB
- Jerome Majoie became a director. NBB
- Bruno Scutnaire became a director. NBB
- New establishment in Mont-Saint-Guibert. KBO
- Richard Zimermann became a director. NBB
- Eric Van Walle became a director. NBB
- Start of the company according to the CBE. KBO
In short
From € 19.6 million profit in 2024 to € 9.3 million profit in 2025.
Paid € 84,101 in corporate taxes since 2024.
Best year ever: 2024, with € 19.6 million profit.
A new publication or filing at The Oncidium Foundation? We notify you, reason included.
Follow The Oncidium FoundationDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind The Oncidium Foundation are Richard Zimermann, Jerome Majoie, Bruno Scutnaire, Soumya Chandramouli and Eric Van Walle. Jerome Majoie is also behind ATB THERAPEUTICS and Inteliphage. Bruno Scutnaire is also behind CONSULYS.
Directors
According to the 2025 annual accounts
Richard Zimermann
Managing director
since 2018
since 2023
since 2019
Soumya Chandramouli
Director
since 2025
Eric Van Walle
Director
since 2011
Establishments
Establishment units
Physical locations of this company
Herrmann-Debrouxlaan 40
1160 Oudergem
Rue du Bosquet 15A
1435 Mont-Saint-Guibert
Active since 1 March 2019
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 20 companies are registered at this address.
All companies at this address →Studiecentrum voor Kernenergie - Centre d'Etude de l'Energie Nucléaire
€ 99.3 million revenue · 2025
European Radiation Research Society
Union internationale des Radioécologistes
Belgian Nuclear Society
Cosmetics Europe - the personal Care Assocaition
€ 8.9 million revenue · 2025
+15 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0838.388.420
- VAT number
- BE 0838.388.420
- Registered office
- Herrmann-Debrouxlaan 40, 1160 Oudergem
- Names & denominations
- The Oncidium Foundation · Oncidium
- Enterprise type
- Rechtspersoon
- Legal form
- Public-interest foundation
- Legal situation
- Normale toestand
- Start date
- 16 June 2011
- Peppol
- Active · Active since 20 Nov 2020
- Activities · NACE
Speur- en ontwikkelingswerk op biotechnologisch gebied